BSEBoard Meeting4d ago · 6 Nov 2026, 01:08 pm
PVP Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve the unaudited standalone and consolidated financial Results for the quarter and half year ended 30th September, 2026
PVP Ventures Ltd · 517556
✦ AI SummaryResults
PVP Ventures Ltd, now known as Evervie Health Ltd, has scheduled a Board Meeting on 13th November 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
PVP Ventures Ltd - 517556 - Board Meeting Intimation for To Consider And Approve The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended 30Th September, 2026.
Attachments (1)
📄pdf
Download →
9c455de2-eca1-46aa-bd88-477960f633d9.pdf
View document text
EVERVIE HEALTH LIMITED
(Formerly known as PVP Ventures Limited)
Date: 6th November, 2026
National Stock Exchange of India Limited BSE Limited
The Manager, Listing Department Corporate Relationship Department
Exchange Plaza, Phiroze Jeejeebhoy Towers,
Bandra Kurla Complex, Bandra (E) Dalal Street, Fort,
Mumbai - 400051 Mumbai - 400001
Equity- Symbol: PVP Equity- Scrip Code: 517556
Debt - 18PVL29A, 18PVL29
Dear Sir/Madam,
Sub: Intimation of Board Meeting under Regulation 29 of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of
Directors of Evervie Health Limited (Formerly Known as PVP Ventures Limited) (“the Company”) is
scheduled to be held on Friday, 13th November, 2026, inter alia, to consider and approve the
Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half
year ended 30th September, 2026.
As informed earlier, the trading window for dealing in the securities of the Company has been closed
for all designated persons and their immediate relatives from 1st October, 2026 and shall remain
closed until 48 hours after the declaration of the said financial results. Thus, the trading window shall
remain closed until, 15th November, 2026.
You are requested to take the above information on record.
Thanking You,
Yours faithfully,
For Evervie Health Limited
(Formerly Known as PVP Ventures Limited)
Prasad V. Potluri
Chairman and Managing Director
DIN: 00179175
EVERVIE HEALTH LIMITED
Registered Office: 9th Floor, KRM Centre, No. 2, Harrington Road, Chetpet, Chennai – 600031, Tamil Nadu.
Corporate Office: 4th Floor, Punniah Plaza, Plot Nos. 83 & 84, Road No. 2, Banjara Hills, Hyderabad – 500034, Telangana.
Tel: Chennai: +91 44 3028 5570 | Hyderabad: +91 40 6730 9999
CIN: L72300TN1991PLC020122 | GSTIN: 36AAACS3101P1ZE
Email: info@everviehealth.com | Website: everviehealth.com